The Challenges and Opportunities of Mesenchymal Stromal Cells in Regenerative Medicine

A special issue of Cells (ISSN 2073-4409).

Deadline for manuscript submissions: 31 March 2026 | Viewed by 5

Special Issue Editor


E-Mail Website
Guest Editor
Department of Biomaterials and Tissue Engineering, Institute of Physiology of the Czech Academy of Sciences, Videnska 1083, 142 20 Prague, Czech Republic
Interests: vascular smooth muscle cells; phenotypic modulation; vascular disease; stem cell differentiation; vascular tissue engineering; regenerative medicine
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

The term "mesenchymal stromal cells" has often been used as a synonym for "mesenchymal stem cells", sharing the common abbreviation “MSCs”. However, mesenchymal stromal cells are a broader group of cells, of which mesenchymal stem cells are a subset. The International Society for Cell and Gene Therapy has characterized mesenchymal stromal cells as a bulk population with remarkable secretory, immunomodulatory, and homing properties, while mesenchymal stem cells have been defined as multipotent adherent cells expressing CD73, CD90, and CD105, lacking the expression of hematopoietic and endothelial markers, and capable of differentiating into specific cell types. In addition, the abbreviation "MSCs" has been used to refer to "medicinal signaling cells", emphasizing their similarity to pericytes and thus their role as sentinel cells of the blood-tissue interface, as well as to "multipotent stem cells", i.e., cells capable of differentiating into multiple but limited cell types, which can be not only mesenchymal but also neural or hematopoietic.

Authors contributing to this Special Issue are invited to further clarify the differences or overlaps between the cell groups for which the abbreviation MSCs has been used in the literature for several decades, using not only conventional best practices but also modern methods of single-cell sequencing, mass cytometry, characterization of extracellular vesicles, and/or microRNA. These new findings will further enhance the benefits and reduce the risks of using mesenchymal stromal cells in regenerative medicine, such as cell therapy and tissue engineering.

Dr. Lucie Bacakova
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • mesenchymal stromal cells
  • mesenchymal stem cells
  • medicinal signaling cells
  • multipotent stem cells
  • paracrine secretion
  • angiogenesis
  • immunomodulation
  • cell therapy
  • cell-free cell-based therapy
  • stem cell differentiation
  • tissue engineering

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers

This special issue is now open for submission.
Back to TopTop